We look forward to connecting with the ALDA community at the 2025 Fall Senior Executive Conference in Zurich. This prestigious event takes place from 12–14 October 2025 and brings together senior leaders to share their visions for the future of the pharma landscape.
Strategic priorities driving innovation in the pharma industry
The program at this year’s ALDA Fall Senior Executive Conference explores the entire pharma ecosystem and the innovations and key trends that are redefining the industry. It covers timely topics including why artificial intelligence (AI) is a gamechanger and how it is transforming drug discovery and development into a faster and more efficient process.
The conference explores in depth the growing momentum of precision medicine and advanced therapies and the impact these have on pipelines, partnerships, supply chain strategies, and technology needs.
Experts focus on what’s ahead in global pharma strategy, investment trends, therapeutic innovation, pricing, and more. They also examine what these trends mean in terms of emerging customer needs, evaluating partnership opportunities, and anticipating shifts in global demand.
The Executive Leadership Panel – made up of senior executives from leading organizations – will highlight key trends and priorities for sustaining innovation, navigating regional complexities, and advancing global health in the years to come.
The opening dinner – with Sir Niall Ferguson, renowned historian, author, and commentator on global politics and economics – will provide a provocative and insightful analysis of the emerging global order and the political and economic uncertainties shaping markets worldwide.
The closing keynote – with the former Prime Minister of Finland, Sanna Marin – will highlight the importance of resilience, adaptability, and international cooperation in today’s volatile world.
Why is this event important to us?
Attending this event enables us to stay at the forefront of innovation, to explore emerging technologies, and to shape the future of lab automation. The ALDA conference enables us to come together with global leaders to collaborate and forge partnerships that support long-term success in the life sciences and diagnostics.
Why should you partner with us?
We have over 30 years of expertise in molecular diagnostics, protein analysis, and cell analysis. Our modular approach based on the use of optimized modular units reduces the time and effort required for development, registration, and life-cycle management (LCM) and decrease COGS (Cost of Goods Sold).
Let’s meet and collaborate
Make an appointment to meet with us at ALDA’s 2025 Fall Senior Executive Conference and let’s drive innovation in healthcare and the life sciences.